267 related articles for article (PubMed ID: 33176208)
1. Treg-dependent immunosuppression triggers effector T cell dysfunction via the STING/ILC2 axis.
Domvri K; Petanidis S; Zarogoulidis P; Anestakis D; Tsavlis D; Bai C; Huang H; Freitag L; Hohenforst-Schmidt W; Porpodis K; Katopodi T
Clin Immunol; 2021 Jan; 222():108620. PubMed ID: 33176208
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of kras-derived exosomes downregulates immunosuppressive BACH2/GATA-3 expression via RIP-3 dependent necroptosis and miR-146/miR-210 modulation.
Petanidis S; Domvri K; Porpodis K; Anestakis D; Freitag L; Hohenforst-Schmidt W; Tsavlis D; Zarogoulidis K
Biomed Pharmacother; 2020 Feb; 122():109461. PubMed ID: 31918262
[TBL] [Abstract][Full Text] [Related]
3. Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3/PTK2 immunosuppressive circuit.
Katopodi T; Petanidis S; Domvri K; Zarogoulidis P; Anestakis D; Charalampidis C; Tsavlis D; Bai C; Huang H; Freitag L; Hohenforst-Schmidt W; Matthaios D; Porpodis K
Sci Rep; 2021 Jul; 11(1):15455. PubMed ID: 34326381
[TBL] [Abstract][Full Text] [Related]
4. Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8
Domvri K; Petanidis S; Zarogoulidis P; Anestakis D; Charalampidis C; Tsavlis D; Huang H; Freitag L; Hohenforst-Schmidt W; Matthaios D; Katopodi T; Porpodis K
Int J Nanomedicine; 2022; 17():4449-4468. PubMed ID: 36172007
[TBL] [Abstract][Full Text] [Related]
5. Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment.
Budhu S; Schaer DA; Li Y; Toledo-Crow R; Panageas K; Yang X; Zhong H; Houghton AN; Silverstein SC; Merghoub T; Wolchok JD
Sci Signal; 2017 Aug; 10(494):. PubMed ID: 28851824
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.
Weiss JM; Subleski JJ; Back T; Chen X; Watkins SK; Yagita H; Sayers TJ; Murphy WJ; Wiltrout RH
J Immunol; 2014 Jun; 192(12):5821-9. PubMed ID: 24808361
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance.
Hibino S; Chikuma S; Kondo T; Ito M; Nakatsukasa H; Omata-Mise S; Yoshimura A
Cancer Res; 2018 Jun; 78(11):3027-3040. PubMed ID: 29559474
[TBL] [Abstract][Full Text] [Related]
8. Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.
Villarreal DO; L'Huillier A; Armington S; Mottershead C; Filippova EV; Coder BD; Petit RG; Princiotta MF
Cancer Res; 2018 Sep; 78(18):5340-5348. PubMed ID: 30026324
[TBL] [Abstract][Full Text] [Related]
9. Increased tumor-infiltrating CD45RA
Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
[TBL] [Abstract][Full Text] [Related]
10. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development.
Li A; Herbst RH; Canner D; Schenkel JM; Smith OC; Kim JY; Hillman M; Bhutkar A; Cuoco MS; Rappazzo CG; Rogers P; Dang C; Jerby-Arnon L; Rozenblatt-Rosen O; Cong L; Birnbaum M; Regev A; Jacks T
Cell Rep; 2019 Dec; 29(10):2998-3008.e8. PubMed ID: 31801068
[TBL] [Abstract][Full Text] [Related]
11. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM
PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594
[TBL] [Abstract][Full Text] [Related]
12. CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade.
Drerup JM; Deng Y; Pandeswara SL; Padrón ÁS; Reyes RM; Zhang X; Mendez J; Liu A; Clark CA; Chen W; Conejo-Garcia JR; Hurez V; Gupta H; Curiel TJ
Cancer Res; 2020 Nov; 80(22):5063-5075. PubMed ID: 32948605
[TBL] [Abstract][Full Text] [Related]
13. Hypothermic microenvironment plays a key role in tumor immune subversion.
Du G; Liu Y; Li J; Liu W; Wang Y; Li H
Int Immunopharmacol; 2013 Oct; 17(2):245-53. PubMed ID: 23831011
[TBL] [Abstract][Full Text] [Related]
14. Chemoresistance in mesenchymal lung cancer cells is correlated to high regulatory T cell presence in the tumor microenvironment.
Zhang LN; Xin T; Chen M; Gao P
IUBMB Life; 2019 Jul; 71(7):986-991. PubMed ID: 31066485
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium infection inhibits the expansion and activation of MDSCs and Tregs in the tumor microenvironment in a murine Lewis lung cancer model.
Adah D; Yang Y; Liu Q; Gadidasu K; Tao Z; Yu S; Dai L; Li X; Zhao S; Qin L; Qin L; Chen X
Cell Commun Signal; 2019 Apr; 17(1):32. PubMed ID: 30979375
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic BRAF
Shabaneh TB; Molodtsov AK; Steinberg SM; Zhang P; Torres GM; Mohamed GA; Boni A; Curiel TJ; Angeles CV; Turk MJ
Cancer Res; 2018 Sep; 78(17):5038-5049. PubMed ID: 30026331
[TBL] [Abstract][Full Text] [Related]
17. NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression.
Okayama H; Saito M; Oue N; Weiss JM; Stauffer J; Takenoshita S; Wiltrout RH; Hussain SP; Harris CC
Int J Cancer; 2013 Jan; 132(1):9-18. PubMed ID: 22618808
[TBL] [Abstract][Full Text] [Related]
18. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
19. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
[TBL] [Abstract][Full Text] [Related]
20. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
